Precigen (PGEN) analyst forecast and price target
Analyst forecast
Consensus of 3 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| HC Wainwright & Co. | Maintained | Buy | $18.00 from $14.00 | Aug 5, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $14.00 | Aug 3, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $14.00 from $11.00 | May 28, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $11.00 from $10.00 | May 14, 2026 |
| Citizens | Maintained | Market Outperform | $11.00 from $9.00 | May 14, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $10.00 from $9.00 | Mar 26, 2026 |
| Citizens | Maintained | Market Outperform | $9.00 from $8.00 | Mar 26, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $9.00 from $8.50 | Nov 14, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $8.50 | Aug 19, 2025 |
| JMP Securities | Maintained | Market Outperform | $8.00 from $6.00 | Aug 19, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $8.50 from $6.00 | Aug 15, 2025 |
| JP Morgan | Upgraded | Underweight → Neutral | — | Aug 15, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $6.00 | Aug 13, 2025 |
| JMP Securities | Maintained | Market Outperform | $6.00 | Jun 12, 2025 |
| Cantor Fitzgerald | Maintained | Overweight | — | May 15, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $6.00 | Mar 20, 2025 |
| Citizens Capital Markets | Maintained | Market Outperform | $6.00 | Mar 20, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $6.00 from $4.00 | Jan 23, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $6.00 from $4.00 | Jan 22, 2025 |
| JMP Securities | Maintained | Market Outperform | $5.00 | Jan 14, 2025 |
Frequently asked questions
Is PGEN a buy, sell, or hold?
Analysts covering Precigen currently average a Buy rating: 2 buy, 1 hold and 0 sell, from 3 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on PGEN?
On Aug 5, 2026, HC Wainwright & Co. maintained Precigen at Buy with a price target of $18.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.